Skip to main navigation Skip to search Skip to main content

Cardiovascular outcomes of type 2 diabetic patients treated with DPP‑4 inhibitors versus sulphonylureas as add-on to metformin in clinical practice

Research output: Contribution to journalArticlepeer-review

4 Scopus citations
Original languageEnglish
Article number23826
JournalScientific Reports
Volume11
Issue number1
DOIs
StatePublished - 1 Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Cardiovascular outcomes of type 2 diabetic patients treated with DPP‑4 inhibitors versus sulphonylureas as add-on to metformin in clinical practice'. Together they form a unique fingerprint.

Cite this